Case 2
Nasopharyngeal Cancer
56 year old woman – Subei Hospital (Yangzhou, China)
She initially presented with nose bleeds and right neck swelling.
Physical Exam: Showed obvious kyphosis, her right neck node was measured 4x3x3cm, and it was hard with no tenderness. Nasopharyngoscopy showed a swelling lesion arising from right lateral wall with parapharyngeal extension. Biopsy was done and pathology reported undifferentiated carcinoma, due to her hunchback, treatment with radiotherapy was difficult. She was chosen to receive UFT and Zhongjiefeng with Huanjngjian (which I created this treatment)
After 2 months treatment, her nose bleed was stopped, and her right neck node was reduced to 1x1cm. I instructed her to continue the same treatment for another five months. Upon re-exam, her right neck node was gone. The nasopharyngoscopy showed the tumor disappeared. Re-biopsy, pathology reported that there is no tumor seen. Since patient blood result was normal, I suggested patient to continue treatment. She took this regimen for total 22 months. She tolerant treatment well without any side effects.
She is disease free with periodic follow up.
(From Oncology Times, Vol.3, NO. 24, p. 13 “Concurrent Chemo + RT Confers Survival Benefit in Nasopharyngeal Carcinoma” (NPC))
Patients- Five years overall survival of patients with stage II NPC.
Qui-yan Chen, MD, PhD, of the Sun yat-Sen University Cancer Center in the people’s republic of China, and colleagues, conducted Phase III trial of patients randomly assigned to receive either RT 114 patients or combined chemo and RT 116 patients. The results also showed that after a median follow up of 60 months, 22.8% of patients in the RT group had disease progression, compared with 11.2% in the concurrent therapy group. 5-years overall survival , progress-free survival were all significantly higher in combined group.
- Metastatic Breast Cancer
- Therapy Comparison
- Case 1: Esophageal Cancer
- Case 2: Nasopharyngeal Cancer
- Case 3: Nasopharyngeal Cancer
- Case 4: Breast Cancer w/ Liver & Bone Mets.
- Case 5: Breast Cancer w/ Bone Mets.
- Case 6: Extranodal NK’T-cell Lymphoma
- Case 7: Breast Cancer Survival w/ Thyroid Tumors
- Case 8: GBM- Glioblastoma-multiform
- Case 9: Recurrent Adenocystic Carcinoma